What are the normal serum hormone ranges for a healthy woman in her 40s?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Hormone Ranges for Women in Their 40s

For healthy women in their 40s, expect FSH levels between 3.8-23.8 IU/L, estradiol 22.4-122.8 pg/mL, LH <11 IU/L, testosterone 15-46 ng/dL (declining from younger decades), and DHEAS approximately 140 μg/dL—though these values vary significantly based on menopausal status and menstrual cycle phase. 1, 2, 3, 4

Key Reproductive Hormones

FSH and LH (Measured Days 3-6 of Cycle)

  • Normal FSH: <35 IU/L indicates premenopausal status 1
  • Normal LH: <11 IU/L 1
  • LH/FSH ratio: Should be <2 in healthy women 1
  • Age-specific FSH for 40-45 year-olds: Geometric mean 9.6 IU/L (95% CI: 3.8-23.8 IU/L) 5
  • Elevated FSH (>35 IU/L) suggests approaching menopause or ovarian insufficiency 1

Important caveat: In women aged 40-45,22% may have normal FSH/estradiol in one cycle but elevated values in the next consecutive cycle, so a single normal measurement doesn't fully characterize reproductive status 5

Estradiol

  • Age 40-45 years: Geometric mean 52.4 pg/mL (95% CI: 22.4-122.8 pg/mL) on day 3 5
  • Upper limit for peak reproductive age (20-25 years): 95.0 pg/mL 5
  • Estradiol varies significantly across the menstrual cycle, with peaks at ovulation 6

Progesterone (Mid-Luteal Phase)

  • Normal: ≥6 nmol/L indicates ovulation 1
  • Low levels (<6 nmol/L) suggest anovulation, commonly seen in PCOS or approaching menopause 1

Androgens

Testosterone

  • Total testosterone (age 30-49): 15-46 ng/dL (520-1595 pmol/L) for a typical 30-year-old 2
  • Age 40-49 years: Mean 33.7 ng/dL, showing significant decline from younger decades 3
  • Free testosterone: 1.2-6.4 pg/mL (4.16-22.2 pmol/L) 2
  • Bioavailable testosterone: 1.12-7.62 ng/dL (38.8-264.21 pmol/L) 2
  • Abnormal elevation: >2.5 nmol/l (measured days 3-6) suggests PCOS or other hyperandrogenic conditions 1

Critical point: Testosterone exhibits a progressive stepwise decline throughout the 40s, with a precipitous drop occurring after the decade of the 20s 3, 4

DHEAS

  • Age 30-39: Upper limit 2700 ng/ml 1
  • Age 40-49: Approximately 140.4 μg/dL, declining from 195.6 μg/dL in the 20s 3
  • Abnormal elevation (>3800 ng/ml in younger women) warrants evaluation for adrenal pathology 1

Other Androgens

  • Androstenedione: <10.0 nmol/L (elevations suggest adrenal/ovarian tumor) 1

Additional Hormones

Prolactin

  • Normal: <20 μg/L (morning resting levels, not postictal) 1
  • Mild elevations may occur in epilepsy; rule out hypothyroidism or pituitary tumor 1

SHBG

  • Normal range: 18-86 nmol/L for a 30-year-old woman 2
  • SHBG remains relatively stable across premenopausal years, unlike declining androgens 3

Thyroid Function

  • TSH: 0.45-4.5 mIU/L (some suggest upper limit of 2.5 mIU/L for optimal function) 7
  • TSH >6.5 mIU/L: Considered elevated and warrants evaluation 8, 9

Menopausal Status Determination

For women in their 40s, menopausal status cannot be reliably determined by amenorrhea alone, especially after chemotherapy or in those on certain medications 10

Criteria for Postmenopausal Status:

  • Age ≥60 years 10
  • Age <60 with amenorrhea ≥12 months (without chemotherapy, tamoxifen, or ovarian suppression) AND FSH/estradiol in postmenopausal range 10
  • If taking tamoxifen/toremifene and age <60: FSH and estradiol must be in postmenopausal ranges 10

Perimenopause Indicators in 40s:

  • Rising FSH (approaching or exceeding 23.8 IU/L) 5
  • Declining inhibin B (<51.7 pg/mL suggests diminished ovarian reserve) 5
  • Cycle irregularity (>35 days oligomenorrhea or <23 days polymenorrhea) 1

Clinical Pitfalls

Intercycle variability is substantial in women in their 40s—always obtain measurements in at least two consecutive cycles before counseling about reproductive potential, as 22% of women aged 40-45 show discordant results between cycles 5

Timing matters: Measure FSH, LH, and testosterone on days 3-6 of the menstrual cycle; progesterone during mid-luteal phase 1, 2

Age-related decline is normal: The dramatic decrease in testosterone and DHEAS after age 30 is physiologic, not necessarily pathologic 3, 4

References

Guideline

reproductive dysfunction in women with epilepsy: recommendations for evaluation and management.

Journal of Neurology, Neurosurgery and Psychiatry, 2002

Guideline

screening for thyroid disease: recommendation statement.

American family physician, 2004

Guideline

screening for thyroid disease: recommendation statement.

Annals of Internal Medicine, 2004

Guideline

invasive breast cancer.

Journal of the National Comprehensive Cancer Network : JNCCN, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.